Interesting applying for ODD. I just looked it up, ~170k TNBC cases in the US per year. But they are indicating this could possibly be used in all ccr5+ tumors, which will be much bigger. Similarly with Combo, the FDA turned it down because of the mono potential, but both treat HIV. Maybe this is different, with different cancer types?